Obsessive-Compulsive Spectrum Disorders: A Review of the Evidence-Based Treatments

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington (DC): APA; 2000.

Hollander E. Obsessive-compulsive-related disorders. Washington (DC): American Psychiatric Press; 1993.

Hollander E. Treatment of obsessive-compulsive spectrum disorders with SSRIs. Br J Psychiatry. 1998;173(Suppl 35):7–12.

Rasmussen SA . Obsessive-compulsive spectrum disorders. J Clin Psychiatry. 1994;55:89–91.

Cohen LS Stein DJ Simeon D , Clinical profile, comorbidity, and treatment history in 123 hair pullers: A survey study. J Clin Psychiatry. 1995;56:319–326.

Swedo SE Leonard HL . Trichotillomania. An obsessive compulsive spectrum disorder? Psychiatr Clin North Am. 1992;15:777–790.

Phillips KA McElroy SL Keck PE , Body dysmorphic disorder: Thirty cases of imagined ugliness. Am J Psychiatry. 1993;150:302–308.

Zimmerman M Matia JI . Body dysmorphic disorder in psychiatric outpatients: Recognition, prevalence, comorbidity, demographic, and clinical correlates. Comp Psychiatry. 1998;39:265–270.

Fallon BA Rasmussen SA Liebowitz MR . Hypochondriasis. In: Hollander E , editor. Obsessive-compulsive related disorders. Washington (DC): American Psychiatric Press; 1993. p 71–92.

Barsky AJ Wyshak G Klerman GL . Psychiatric comorbidity in DSM-III-R hypochondriasis. Arch Gen Psychiatry. 1992;49:101–108.

Arnold LM McElroy SL Mutasim DF , Characteristics of 34 adults with psychogenic excoriation. J Clin Psychiatry. 1998;59:509–514.

Wilhelm S Keuthen NJ Deckersbauch T , Self-injurious skin picking: Clinical characteristics and comorbidity. J Clin Psychiatry. 1999;60:454–459.

Linden RD Pope HG Jr Jonas JM . Pathological gambling and major affective disorder: Preliminary findings. J Clin Psychiatry. 1986;47:201–203.

Hollander E Benzaquen SD . The obsessive-compulsive spectrum disorder. In: den Boer JA Westenberg HGM , editors. Focus on obsessive compulsive spectrum disorders. Amsterdam (NL): Syn-Thesis Publishers; 1997. p 33–44.

Pauls DL Alsobrook JP Goodman WK , A family study of obsessive compulsive disorder. Am J Psychiatry. 1995;152:76–84.

Lenane MC Swedo SE Rapoport JL , Rates of obsessive compulsive disorder in first degree relatives of patients with trichotillomania: A research note. J Child Psychol Psychiatry. 1992;33:925–933.

McElroy SL Pope HG Hudson JI , Kleptomania: A report of 20 cases. Am J Psychiatry. 1991;148:652–657.

Hollander E Wong CM . Obsessive-compulsive spectrum disorders. J Clin Psychiatry. 1995;56(Suppl 4):3–6.

Linnoila M Virkunen M Scheinin M , Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 1983;33:2609–2614.

Leckman JF Goodman WK Anderson GM , Cerebrospinal fluid biogenic amines in obsessive-compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology. 1995;12:73–86.

Bergh C Eklund T Sodersten P , Altered dopamine function in pathological gambling. Psychol Med 1997;27:473–475.

Stein DJ Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psychiatry. 1992;53:123–126.

Stein DJ Bouwer C Hawkridge S , Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. J Clin Psychiatry. 1997;58:119–122.

Van Ameringen M Mancini C Oakman JM , The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord. 1999;56:219–226.

Moreno I Saiz-Ruiz J Lopez-Ibor Aliño JJ . Serotonin and gambling dependence. Human Psychopharmacol. 1991;6:S9–S12.

Roy A Adinoff B Roehrick L , Pathological gambling: A psychobiological study. Arch Gen Psychiatry. 1988;45:369–373.

Roy A De Jong J Linnoila M. Extraversion in pathological gamblers. Correlates with indexes of noradrenergic function. Arch Gen Psychiatry. 1989;46:679–681.

Phillips KA . The obsessive-compulsive spectrum: Promises and pitfalls. In: Maj M Sartorius N Okasha A , editors. Obsessive-compulsive disorder. Chichester (UK): John Wiley and Sons Ltd; 2000. p 225–227.

Black DW . The obsessive-compulsive spectrum: Fact or fancy? In: Maj M Sartorius N Okasha A , editors. Obsessive-compulsive disorder. Chichester (UK): John Wiley and Sons Ltd; 2000. p 233–235.

McElroy SL Pope HG Jr Keck PE Jr Are impulse control disorders related to bipolar disorder? Compr Psychiatry. 1996;37:229–240.

Yatham LN Kennedy SH O'Donovan C , Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: Consensus and controversies. Bipolar Disord. 2005:7(Suppl 3):5–69.

Phillips KA McElroy SL . Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder: Theoretical and treatment implications. J Nerv Ment Dis. 1993;181:699–702.

Veale D Boocock A Gournay K , Body dysmorphic disorder: A survey of fifty cases. Br J Psychiatry. 1996;169:196–201.

Phillips KA Gunderson CG Mallya G , A comparison study of body dysmorphic disorder and obsessive-compulsive disorder. J Clin Psychiatry. 1998;59:568–575.

Rich N Rosen JC Orosan PG . Prevalence of body dysmorphic disorder in non-clinical populations. Presented at the 26th annual convention of the Association for the Advancement of Behavior Therapy; 1992 November 2; Boston (MA).

Neziroglu F Hsia C Yaryura-Tobias JA . Behavioral, cognitive, and family therapy for obsessive-compulsive and related disorders. Psychiatr Clin North Am. 2000;23:657–670.

Veale D Gournay K Dryden W , Body dysmorphic disorder: A cognitive behavioural model and pilot randomised controlled trial. Behav Res Ther. 1996;34:717–729.

Phillips KA McElroy SL Keck PE Jr A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull. 1994;30:179–186.

Phillips KA McElroy SL Gunderson CG , Body dysmorphic disorder: Data on imagined ugliness. Presented at the 147th annual meeting of the American Psychiatric Association; 1994 May 22: Philadelphia (PA).

Hollander E Cohen LJ Simeon D. Body dysmorphic disorder. Psychiatr Ann. 1993;23:359–644.

Phillips KA Albertini RS Rasmussen SA . A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry. 2002;59:381–388.

Phillips KA Rasmussen SA . Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: A placebo-controlled study. Psychosomatics. 2004;45:438–444.

Phillips KA Dwight MM McElroy SL . Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 1998;59:165–171.

Perugi G Giannotti D Di Vaio S , Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol. 1996;11:247–254.

Hollander E Allen A Kwon J , Clomipramine vs desipramine crossover trial in body dysmorphic disorder: Selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry. 1999;56:1033–1039.

Phillips KA . An open-label study of escitalopram in body dysmorphic disorder. Int Clin Psychopharmacol. 2006;21:177–179.

Phillips KA Najjar F. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry. 2003;64:715–720.

Phillips KA Pagano ME Menard W. Pharmacotherapy for body dysmorphic disorder: Treatment received and illness severity. Ann Clin Psychiatry. 2006;18:251–257.

Rosen J. The nature of body dysmorphic disorder and treatment with cognitive behavior therapy. Cogn Behav Pract. 1995;2:143–166.

McKay D Todaro J Neziroglu F , Body dysmorphic disorder: A preliminary evaluation of treatment and maintenance using exposure with response prevention. Behav Res Ther. 1997;35:67–70.

Rosen JC Reiter J Orosan P. Cognitive-behavioral body image therapy for body dysmorphic disorder. J Consult Clin Psychol. 1995;63:263–269.

Saxena S Winograd A Dunkin JJ , A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder. J Clin Psychiatry. 2001;62:67–72.

Fallon BA Liebowitz MR Salmon E , Fluoxetine for hypochondriacal patients without major depression. J Clin Psychopharmacol. 1993;13:438–441.

Greeven A van Balkom AJ Visser S , Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: A randomized controlled trial. Am J Psychiatry. 2007;164:91–99.

Fallon BA Quereshi AI Schneier FR , An open trial of fluvoxamine for hypochondriasis. Psychosomatics. 2003;44:298–303.

Pilkowsky I. The response to treatment in hypochondriacal disorders. Aust N Z J Psychiatry. 1968;2:88–94.

Thomson A Page L. Psychotherapies for hypochondriasis. Cochrane Database Syst Rev. 2007;4:CD006520.

Warwick H Clark D Salkovskis P. A controlled trial of cognitive-behavioural treatment of hypochondriasis. Br J Psychiatry. 1996;169:189–95.

Barsky AJ Ahern DK . Cognitive behavior therapy for hypochondriasis: A randomized controlled trial. JAMA. 2004;291:1464–1470.

Clark DM Salkovskis PM Hackmann A , Two psychological treatments for hypochondriasis: A randomized controlled trial. Br J Psychiatry. 1998;173:218–225.

Visser S Bouman TK . The treatment of hypochondriasis: Exposure plus response prevention vs cognitive therapy. Behav Res Ther. 2001;39:423–442.

Kellner R. The prognosis of treated hypochondriasis: A clinical study. Acta Psychiatr Scand. 1983;67:69–79.

Fava GA Grandi S Rafanelli C , Explanatory therapy in hypochondriasis. J Clin Psychiatry. 2000;61:317–322.

Bouman TK . A community-based psychoeducational group approach to hypochondriasis. Psychother Psychosom. 2002;71:326–332.

Christenson GA Pyle RL Mitchell JE . Estimated lifetime prevalence of trichotillomania in college students. J Clin Psychiatry. 1991;52:415–417.

Rothbaum BO Shaw L Morris R , Prevalence of trichotillomania in a college freshman population. J Clin Psychiatry. 1993;54:73.

Swedo S Leonard H Lenane M , Trichotillomania: A profile of the disorder from infancy through adulthood. Int Pediatr. 1992;7:144–150.

Winchel RM Jones JS Stanley B , Clinical characteristics of trichotillomania and its response to fluoxetine. J Clin Psychiatry. 1992;53:304–308.

van Minnen A Hoogduin KA Keijsers GP , Treatment of trichotillomania with behavioural therapy or fluoxetine: A randomized, waiting-list controlled study. Arch Gen Psychiatry. 2003;60:517–522.

Christenson GA MacKenzie TB Mitchell JE , A placebo-controlled double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry. 1991;148:1566–1571.

Streichenwein SM Thornby JI . A long-term, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am J Psychiatry. 1995;152:1192–1196.

Stanley MA Breckenridge JK Swann AC . Fluvoxamine treatment of trichotillomania. J Clin Psychopharmacol. 1997;17:278–283.

Dougherty DD Loh R Jenike MA , Single modality versus dual modality treatment for trichotillomania: Sertraline, behavioral therapy, or both? J Clin Psychiatry. 2006;67:1086–1092.

Gadde KM Ryan Wagner H Connor KM , Escitalopram treatment of trichotillomania. Int Clin Psychopharmacol. 2007;22:39–42.

Swedo SE Leonard HL Rapoport JL , A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med. 1989;321:497–501.

Ninan PT Rothbaum BO Marsteller FA , A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. J Clin Psychiatry. 2000;61:47–50.

Bloch MH Landeros-Weisenberger A Dombrowski P , Systematic review: Pharmacological and behavioral treatment for trichotillomania. Biol Psychiatry. 2007;62:839–846.

Stewart RS Nejtek VA . An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. J Clin Psychiatry. 2003;64:49–52.

Christenson GA Crow SJ MacKenzie TB , A placebo controlled double-blind study of naltrexone for trichotillomania. Poster presented at the American Psychiatric Association Annual Meeting; 1994 May; Philadelphia (PA).

Lochner C Seedat S Niehaus DJ , Topiramate in the treatment of trichotillomania: An open-label pilot study. Int Clin Psychopharmacol. 2006;21:255–259.

Azrin NH Nunn RG Frantz SE . Treatment of hair-pulling (trichotillomania): A comparative study of habit reversal and negative practice training. J Behav Ther Exp Psychiatry. 1980;11:13–20.

Woods DW Wetterneck CT Flessner CA . A controlled evaluation of acceptance and commitment therapy plus habit reversal for trichotillomania. Behav Res Ther. 2006;44:639–656.

Diefenbach GJ Tolin DF Hannan S , Group treatment for trichotillomania. Behav Ther. 2006;37:353–363.

Keijsers GP van Minnen A Hoogduin CA , Behavioural treatment of trichotillomania: Two-year follow-up results. Behav Res Ther. 2006;44:359–370.

Rothbaum BO . The behavioral treatment of trichotillomania. Behav Psychother. 1992;20:85–89.

Gluhoski VL . A cognitive approach for treating trichotillomania. J Psychother Pract Res. 1995;4:277–285.

Tolin DF Franklin ME Diefenbach GJ , Pediatric trichotillomania: Descriptive psychopathology and an open trial of cognitive behavioral therapy. Cogn Behav Ther. 2007;36:129–144.

Lorenz VC Yaffee RA . Pathological gambling: Psychosomatic, emotional and marital difficulties as reported by the gambler. J Gambl Behav. 1986;2:40–49.

Berg C Kuhlhorn E. Social, psychological, and physical consequences of pathological gambling in Sweden. J Gambl Stud. 1994;10:275–285.

National Council on Problem Gambling. National Council on Problem Gambling Research and Public Policy Committees: Problem and pathological gambling in America: The national picture. Columbia (MD): National Council on Problem Gambling; 1997.

Crockford DN el-Guebaly N. Psychiatric comorbidity in pathological gambling: A critical review. Can J Psychiatry. 1998;43:43–50.

Lesieur HR Klein R. Gambling and pathological gambling among high school students. Addict Behav. 1987;12:129–135.

Zimmerman M Breen RB Posternak MA . An open-label study of citalopram in the treatment of pathological gambling. J Clin Psychiatry. 2002;63:44–48.

Grant JE Potenza MN . Escitalopram treatment of pathological gambling with co-occurring anxiety: An open-label pilot study with double-blind discontinuation. Int Clin Psychopharmacol. 2006;21:203–209.

Black DW Shaw M Forbush KT , An open-label trial of escitalopram in the treatment of pathological gambling. Clin Neuropharmacol. 2007;30:206–212.

Kim SW Grant JE Adson DE , A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry. 2002;63:501–507.

Ravindran A Telner J Bhatla R , Treating pathological gambling with cognitive behaviour therapy and paroxetine: Treatment response, remission and predictors. Paper presented at the Canadian Psychiatric Association Annual Meeting; 2006 November; Toronto (ON).

Saiz-Ruiz J Blanco C Ibanez A , Sertraline treatment of pathological gambling: A pilot study. J Clin Psychiatry. 2005;66:28–33.

Hollander E DeCaria C Mari E , Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry. 1998;155:1781–1783.

Hollander E DeCaria CM Finkell JN , A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol Psychiatry. 2000;47:813–817.

Blanco C Petkova E Ibáòez A , A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry. 2002;14:9–15.

Hollander E Pallanti S Allen A , Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry. 2005;162:137–145.

Pallanti S Quercioli L Sood E , Lithium and valproate treatment of pathological gambling: A randomized single-blind study. J Clin Psychiatry. 2002;63:559–564.

Grant JE Kim SW . Effectiveness of pharmacotherapy for pathological gambling: A chart review. Ann Clin Psychiatry. 2002;14:155–161.

Kim SW Grant JE . An open naltrexone treatment study in pathological gambling disorder. Int Clin Psychopharmacol. 2001;16:285–289.

Kim SW Grant JE Adson DE , Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry. 2001;49:914–921.

Dannon PN Lowengrub K Musin E , Sustained-released bupropion versus naltrexone in the treatment of pathological gambling: A preliminary blind-rater study. J Clin Psychopharmacol. 2005;25:593–596.

Black DW . An open-label trial of bupropion in the treatment of pathological gambling. J Clin Psychopharmacol. 2004;24:108–110.

Black DW Arndt S Coryell WH , Bupropion in the treatment of pathological gambling: A randomized, double-blind, placebo-controlled, flexible-dose study. J Clin Psychopharmacol. 2007;27:143–150.

Dannon PN Lowengrub K Gonopolski Y , Topiramate versus fluvoxamine in the treatment of pathological gambling: A randomized, blind-rater comparison study. Clin Neuropsychopharmacol. 2005;28:6–10.

Pallanti S Baldini Rossi N Sood E , Nefazodone treatment of pathological gambling: A prospective open-label controlled trial. J Clin Psychiatry. 2002;63:1034–1039.

Grant JE Potenza MN Hollander E , Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006;163:180–181.

Grant JE Kim SW Odlaug BL . N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: A pilot study. Biol Psychiatry. 2007;62:652–657.

Pallesen S Molde H Arnestad HM , Outcome of pharmacological treatments of pathological gambling: A review and meta-analysis. J Clin Psychopharmacol. 2007;27:357–364.

McConaghy N Armstrong MS Blaszczynski A , Controlled comparison of aversive therapy and imaginal desensitization in compulsive gambling. Br J Psychiatry. 1983;142:366–372.

McConaghy N Blasczynski A Frankova A. Comparison of imaginal desensitization with other behavioural treatments of pathological gambling. A two- to nine-year follow-up. Br J Psychiatry. 1991;159:390–393.

Echeburua E Baez C Fernandez-Montalvo J. Comparative effectiveness of three therapeutic modalities in the psychological treatment of pathological gambling. Behav Cogn Psychother. 1996;24:51–72.

Echeburua E Fernandez-Montalvo J Baez C. Relapse prevention in the treatment of slot-machine pathological gambling: Long-term outcome. Behav Ther. 2000;31:351–364.

Ladouceur R Sylvain C Boutin C , Cognitive treatment of pathological gambling. J Nerv Ment Dis. 2001;189:774–780.

Sylvain C Ladouceur R Boisvert JM . Cognitive and behavioral treatment of pathological gambling: A controlled study. J Consult Clin Psychol. 1997;65:727–732.

Dowling N Smith D Thomas T. Treatment of female pathological gambling: The efficacy of a cognitive-behavioural approach. J Gambl Stud. 2006;22:355–372.

Ladouceur R Sylvain C Boutin C , Group therapy for pathological gamblers: A cognitive approach. Behav Res Ther. 2003;41:587–596.

Dowling N Smith D Thomas T. A comparison of individual and group cognitive-behavioural treatment for female pathological gambling. Behav Res Ther. 2007;45(9):2192–2202. Epub 2006 Dec 28.

Bados A Balaguer G Saldana C. The efficacy of cognitive-behavioral therapy and the problem of drop-out. J Clin Psychol. 2007;63:585–592.

Melville KM Casey LM Kavanagh DJ . Psychological treatment dropout among pathological gamblers. Clin Psychol Rev. 2007;27:944–958.

Stewart RM Brown RIF . An outcome study of Gamblers Anonymous. Br J Psychiatry. 1988;152:284–288.

Lester D. The treatment of compulsive gambling. Int J Addict. 1980;15:201–206.

Brown RIF . The effectiveness of Gamblers Anonymous. In: Eadington WR , editor. The gambling studies. Proceedings of the Sixth National Conference on Gambling and Risk Taking. Reno (NV): Bureau of Business and Economic Administration, University of Nevada; 1985.

Lesieur HR Blume SB . Evaluation of patients treated for pathological gambling in a combined alcohol, substance abuse, and pathological gambling treatment unit using the Addiction Severity Index. Br J Addict. 1991;86:1017–1028.

Russo AM Taber JI McCormick RA , An outcome study of an inpatient treatment program for pathological gamblers. Hosp Community Psychiatry. 1984;35:823–827.

Petry NM Ammerman Y Bohl J , Cognitive-behavioral therapy for pathological gamblers. J Consult Clin Psychol. 2006;74:555–567.

Petry NM Litt MD Kadden R , Do coping skills mediate the relationship between cognitive-behavioral therapy and reductions in gambling in pathological gamblers? Addiction. 2007;102:1280–1291.

Hodgins DC Currie S El-Guebaly N. Motivational enhancement and self-help treatments for problem gambling. J Consult Clin Psychol. 2001;69:50–57.

Hodgins DC Currie S El-Guebaly N , Brief motivational treatment for problem gambling: A 24-month follow-up. Psychol Addict Behav. 2004;18:293–296.

Wulfert E Blanchard EB Freidenberg BM , Retaining pathological gamblers in cognitive behavior therapy through motivational enhancement: A pilot study. Behav Modif. 2006;30:315–340.

McElroy SL Keck PE Pope HG , Compulsive buying: A report of 20 cases. J Clin Psychiatry. 1994;55:242–248.

Black DW . Compulsive buying: A review. J Clin Psychiatry. 1996;57(Suppl 8):50–55.

Faber RJ O'Guinn RJ . A clinical screener for compulsive buying. J Consum Res. 1992;19:459–469.

Koran LM Bullock KD Hartston HJ , Citalopram treatment of compulsive shopping: An open-label study. J Clin Psychiatry. 2002;63:704–708.

Koran LM Chuong HW Bullock KD , Citalopram for compulsive shopping disorder: An open-label study followed by double-blind discontinuation. J Clin Psychiatry. 2003;64:793–798.

Koran LM Aboujaoude EN Solvason B , Escitalopram for compulsive buying disorder: A double-blind discontinuation study. J Clin Psychopharmacol. 2007;27:225–227.

Black DW Monahan P Gabel J. Fluvoxamine in the treatment of compulsive buying. J Clin Psychiatry. 1997;58:159–163.

Black DW Gabel J Hansen J , A double-blind comparison of fluvoxamine versus placebo in the treatment of compulsive buying disorder. Ann Clin Psychiatry. 2000;12:205–211.

Ninan PT McElroy SL Kane CP , Placebo-controlled study of fluvoxamine in the treatment of patients with compulsive buying. J Clin Psychopharmacol. 2000;20:362–366.

Black DW . Recognition and treatment of obsessive-compulsive spectrum disorders. In: Swinson RP Antony MM Rachman S , editors. Obsessive-compulsive disorder: Theory, research, and treatment. New York (NY): Guildford Publications Inc; 1998. p 426–457.

Mitchell JE Burgard M Faber R , Cognitive behavioral therapy for compulsive buying disorder. Behav Res Ther. 2006;44:1859–1865.

Koran LK Aboujaoude EN Gamel NN . Escitalopram treatment of kleptomania: An open-label trial followed by double-blind discontinuation. J Clin Psychiatry. 2007;3:422–427.

Grant JE Kim SW . An open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry. 2002;63:349–355.

Grant JE . Outcome study of kleptomania patients treated with naltrexone: A chart review. Clin Neuropharmacol. 2005;28:11–14.

Stein DJ Hollander E. Dermatology and conditions related to obsessive-compulsive disorder. J Am Acad Dermatol. 1992;26:237–242.

Phillips KA Taub SL . Skin picking as a symptom of body dysmorphic disorder. Psychopharmacol Bull. 1995;31:279–288.

Simeon D Stein DJ Hollander E. Depersonalization disorder and self-injurious behavior. J Clin Psychiatry. 1995;56(Suppl 4):36–39.

Leonard HL Lenane MC Swedo SE , A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting). Arch Gen Psychiatry. 1991;48:821–827.

Simeon D Stein DJ Gross S , A double-blind trial of fluoxetine in pathologic skin picking. J Clin Psychiatry. 1997;58:341–347.

Bloch MR Elliott M Thompson H , Fluoxetine in pathological skin-picking: Open-label and double-blind results. Psychosomatics. 2001;42:314–319.

Arnold LM Mutasim DF Dwight MM , An open clinical trial of fluvoxamine treatment of psychogenic excoriation. J Clin Psychopharmacol. 1999;19:15–18.

Kalivas J Kalivas L Gilman D , Sertraline in the treatment of neurotic excoriations and related disorders. Arch Dermatol. 1996;132:589–590.

Keuthen NJ Jameson M Loh R , Open-label escitalopram treatment for pathological gambling. Int Clin Psychopharmacol. 2007;22:268–274.

Grant JE Odlaug BL Kim SW . Lamotrigine treatment of pathologic skin picking: An open-label study. J Clin Psychiatry. 2007;68:1384–1391.

Silber KP Haynes CE . Treating nailbiting: A comparative analysis of mild aversion and competing response therapies. Behav Res Ther. 1992;30:15–22.

Allen KW . Chronic nailbiting: A controlled comparison of competing response and mild aversion treatments. Behav Res Ther. 1996;34:269–272.

Twohig MP Woods DW Marcks BA , Evaluating the efficacy of habit reversal: Comparison with a placebo control. J Clin Psychiatry. 2003;64:40–48.

Teng EJ Woods DW Twohig MP . Habit reversal as a treatment for chronic skin picking: A pilot investigation. Behav Modif. 2006;30:411–422.

Frost GR Steketee G , editors. Cognitive approaches to obsessions and compulsions: Theory, assessment, and treatment. New York (NY): Elsevier Science; 2002.

Bloch MH Landeros-Weisenberger A Kelmendi B , A systematic review: Antipsychotic augmentation of treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006;11:622–632.

Sareen J Kirshner A Lander M , Do antipsychotics ameliorate or exacerbate obsessive-compulsive disorder symptoms? A systematic review. J Affect Disord. 2004;82:167–174.